Actively Recruiting

Age: 16Years - 100Years
All Genders
NCT00001465

Study of the Disease Process of Lymphangioleiomyomatosis

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-05-07

2000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Pulmonary lymphangioleiomyomatosis (LAM) is a destructive lung disease typically affecting women of childbearing age. Currently, there is no effective therapy for the disease and the prognosis is poor. This study is designed to determine the disease processes involved at the level of cells and molecules, in order to develop more effective therapy. Researchers intend to identify the proteins and genes that contribute to the process of lung destruction in affected individuals. ...

CONDITIONS

Official Title

Study of the Disease Process of Lymphangioleiomyomatosis

Who Can Participate

Age: 16Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Lung biopsy showing lymphangioleiomyomatosis (LAM) or chest x-ray/CT scan consistent with LAM
  • Patients with tuberous sclerosis complex (TSC) and pulmonary LAM
  • Normal non-smokers with no systemic or lung disease and no smoking for 1 year or more (control group)
  • Normal smokers with no systemic or lung disease, smoking for 1 year or more, normal chest x-ray and lung function (control group)
  • Pregnant or nursing women can be included but will not undergo higher-risk procedures during pregnancy or nursing
Not Eligible

You will not qualify if you...

  • Age under 16 years
  • Advanced pulmonary or systemic illness posing significant risk during study procedures
  • Use of continuous oxygen for formal exercise or stress echocardiogram studies (exercise test may still be performed)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

T

Tatyana A Worthy, R.N.

CONTACT

J

Joel Moss, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here